|
|
|
March 14, 2012 The entire staff at the Mesothelioma Research Foundation of America stops and takes a deliberate moment to recognize and send a sincere thanks to the JOHNS for their donation of $5,000 designated for mesothelioma cancer research. The JOHNS event is held annually to honor a dear deceased friend, John S. Lyons, by acknowledging today's Labor Leader of the Year as well as raise money for cancer research and other local charities. November 14, 2011 Learn about Veglin at this MesoRFA link: read more... And learn about participating in a clinical trial at this MesoRFA link: Bring your questions to Dr. Gill: click HERE September 10, 2011 Mar 19, 2011 DONATIONS for cancer cure 100 percent of all proceeds received are going to the USC Norris Comprehensive Cancer Medical Center in Los Angeles to support the FDA Phase III of Dr. Gill's clinical trials. These trials are for Veglin, a mesothelioma cancer treatment. Veglin manipulates the blood vessels to starve a malignant tumor while alleviating fluid build up in the lungs Support the hope in this research and click HERE Patient Assistance Programs are offered by many pharmaceutical manufacturers to help pay for medications. These offers are sometimes called Indigent Drug Programs. Use our link just following, and learn whether a specific drug might be available at reduced cost or for free. Drug Assistance Programs: click HERE At the Mesothelioma Research Foundation of America, you can call toll free (800) 909-Meso (6376) to talk with one of our Cancer Information Specialists who will gladly look up the phone numbers or the web site of the pharmaceutical company that makes the drug you are using Find the lastest Mesothelioma clinical trials: click HERE To ask Dr. Gill a question: click HERE Help this Foundation and click HERE
Financial help for cancer patients: click HERE At the Mesothelioma Research Foundation of America, you can call toll free (800) 909-Meso (6376) to talk with one of our Cancer Information Specialists who will gladly look up the phone numbers or the web site of organizations that provide financial assistance. Bring your questions to Dr. Gill: click HERE Help grow the Foundation and cancer-cure research: click HERE |
On November 14, 2011, Dr. Parkash Gill announced that Veglin is not released yet to restart it's Phase 2 Clinical Trials, and the project continues to wait for FDA approval. Dr. Gill is working hard to restart Veglin within Phase 2 and is also working diligently to get EPH-B4 into Phase I Clinical Trials.
Please use our FaceBook link
to obtain your FREE copy of our eBook that teaches you 10 easy steps on how to find and choose a clinical trial for Mesothelioma and how to prepare for it!
Ask Dr. Gill about your specific mesothelioma issues here: Ask Dr. Gill
Learn more about Veglin at this cancer research link: read more...
In addition to the eBook found at our Facebook fan page, also learn more about clinical trials from these links:
The Mesothelioma Research Foundation of America has a mission: fund research that will lead to the quickest cure for mesothelioma. Mesothelioma is a cancer of the lining of the lungs caused by asbestos exposure. This cancer disease had few treatment options until this Foundation and Dr. Parkash Gill's work created better treatment options. Today, the future looks more hopeful for additional improved treatment options available to those stricken by this cancer.

The Mesothelioma Research Foundation of America began funding research for a cure in 2001 with the opening of the Mesothelioma Laboratory at USC Norris Comprehensive Cancer Medical Center in Los Angeles under the supervision of Dr. Parkash Gill.
Dr. Gill is a board certified oncologist and hematologist who has received FDA approval from the U.S. Government to do Clinical Trials on a mesothelioma treatment drug called Veglin. We believe there is great promise and hope in Veglin and the Mesothelioma Research Foundation of America has funded 100% of Dr. Gill's research.
Veglin proved successful in Phase I and Phase II clinical trials. Many are very hopeful for the possibilities of a more effective cancer treatment compared to what presently is available for mesothelioma victims. We are currently waiting for further FDA approval to move into Phase III clinical trials.
For questions related to the foundation and to make contributions please contact:
Executive Director
Toll Free:
(800) 909-Meso (6376)
5716 Corsa Avenue, Suite 203
Westlake Village, CA 91362
For more information and other questions contact:
©2012 Mesothelioma Research Foundation Of America